A single center study of mepolizumab in eosinophilic granulomatosis with polyangiitis patients
Latest Information Update: 25 Jun 2021
At a glance
- Drugs Mepolizumab (Primary)
- Indications Granulomatosis with polyangiitis
- Focus Therapeutic Use
- 25 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism